{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Survey Questionnaire

(Kindly fill in the relevant information or tick, as appropriate.)

Dear Doctor,
The objective of this questionnaire is to obtain clinical insights to understand the need gap and place of tofacitinib in the management of rheumatoid arthritis.
  1. How many patients of rheumatoid arthritis do you see in a week in your practice? *

  2. What are the tests do you do to diagnose a case of rheumatoid arthritis? (Multiple options can be selected) *
  3. Among rheumatoid arthritis patients what is the percentage of patients who have moderately to severely active disease in your practice? *

  4. What percentage of moderately to severely active rheumatoid arthritis patients do not adequately respond to conventional DMARDs in your practice? *

  5. What is your preferred choice of treatment in the management of patients non responsive to DMARDS from below options? *

  6. If you prefer to prescribe Tofacitinib, how many moderately active RA patients do you prefer to prescribe Tofacitinib in a week? *

  7. What %age of the patients on inj biologics have incidence of infusion reaction? *

  8. What is your preferred choice among two formulations of tofacitinib for the management of moderately to severely active rheumatoid arthritis? *

  9. What is your preferred regimen for the management of moderate to severe active RA? *

  10. How long does it take to get remission on tofacitinib 5 mg twice daily/11 mg once daily in moderately to severely active rheumatoid arthritis? *

  11. When do you shift the dose of tofacitinib 5 mg BID to 5 mg OD in the management of moderately to severely active rheumatoid arthritis? *

  12. How many patients reported reactivation of pulmonary or extra pulmonary tuberculosis while taking tofacitinib for rheumatoid arthritis? *

  13. : How many patients reported below adverse event while taking tofacitinib for the treatment of rheumatoid arthritis? *
    14. %
    %
    %
    %
    %
  14. How many patients discontinue or show poor compliance to the prescribed dosage of tofacitinib 11 mg formulation? *

  15. Which indications do you prefer to use Tofacitinib other than active RA cases? *